For Doctors in a Hurry
- Clinicians need to determine if endovascular treatment improves tissue preservation in patients with medium or distal vessel occlusion strokes.
- The study analyzed imaging data from 447 patients randomized to receive either endovascular treatment plus medical therapy or medical therapy alone.
- Patients receiving endovascular treatment showed a 1.6 adjusted odds ratio for preserving at least 80 percent of at-risk brain tissue.
- The researchers concluded that endovascular treatment significantly increases the likelihood of favorable imaging outcomes compared to medical therapy alone.
- Preserving at least 80 percent of at-risk tissue correlates with improved clinical outcomes at 90 days for these stroke patients.
Expanding the Boundaries of Endovascular Reperfusion
Mechanical thrombectomy is the definitive standard of care for acute ischemic stroke involving proximal large vessel occlusions, significantly reducing long-term disability when administered within narrow therapeutic windows [1, 2]. However, the clinical benefit of extending endovascular intervention to medium or distal vessel occlusions remains a subject of active debate, as these territories often present unique technical challenges and variable natural histories [3, 4]. Current guidelines emphasize the urgency of reperfusion, yet clinicians frequently face uncertainty when deciding whether the risks of distal catheterization outweigh the potential for tissue salvage [5, 6]. While imaging-based selection has refined the approach to proximal clots, its utility in predicting outcomes for more distal targets is not yet fully characterized [7]. A new analysis of the Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels (DISTAL) trial now evaluates how endovascular techniques impact the preservation of brain tissue specifically in these distal territories.
Quantifying Tissue Salvage in Distal Territories
This investigation was a post hoc imaging analysis of the DISTAL trial, a multicenter randomized clinical trial with blinded end point assessment conducted across 55 hospitals in 11 countries between December 2021 and July 2024. The analysis included 447 patients, of whom 252 (56.4%) were male, with a median age of 77.0 years (interquartile range [IQR], 68.0 to 84.0 years). By focusing on this specific cohort, the researchers sought to determine if mechanical intervention could effectively halt the progression of ischemia in smaller vascular territories that are often managed conservatively. The primary outcome was the change in the relative volume of preserved tissue (Vrel), a ratio calculated as the difference between the volume of brain tissue initially at risk and the final infarct volume, divided by the total volume of tissue at risk. To provide a clinically relevant benchmark for success, the researchers defined a good imaging outcome as a Vrel of 0.8 or greater, meaning that at least 80% of the brain tissue identified as being at risk on baseline perfusion imaging was successfully salvaged and did not progress to permanent infarction at the 24 hour follow up mark. This quantitative approach allows for a precise assessment of how much vulnerable parenchyma is protected by endovascular therapy compared to medical management alone, offering a more granular view of treatment efficacy than clinical scales alone.
Comparative Imaging Outcomes at 24 Hours
The study population was divided into 226 individuals receiving endovascular treatment (EVT) plus best medical treatment (BMT) and 221 patients receiving BMT alone. To be eligible for this imaging substudy, patients required baseline perfusion imaging and follow up imaging at a median of 22.9 hours (IQR, 19.2 to 25.5 hours). At presentation, the median volume of tissue at risk was 34.0 mL (IQR, 20.0 to 50.0 mL), as measured by the Tmax6 volume (the volume of brain tissue where the arrival of contrast agent is delayed by more than 6 seconds, a common marker for the ischemic penumbra). Across the entire cohort, the median follow up infarct volume was 7.0 mL (IQR, 1.0 to 22.9 mL). When comparing the two treatment arms, endovascular intervention resulted in a significantly higher volume of salvaged parenchyma. The median change in the absolute volume of preserved tissue was 23.6 mL (IQR, 5.7 to 38.9 mL) in the EVT plus BMT group, compared to 14.8 mL (IQR, 0 to 30.3 mL) in the BMT group. This difference in absolute salvage translated to superior relative preservation metrics, as the median change in Vrel was 0.8 (IQR, 0.2 to 1.0) for patients treated with thrombectomy, whereas the median Vrel was 0.6 (IQR, 0 to 0.9) for those receiving medical management alone. The odds for reaching a Vrel of 0.8 or greater were higher in the EVT plus BMT group compared with BMT alone (adjusted odds ratio [aOR], 1.6; 95% CI, 1.1 to 2.3), suggesting that mechanical intervention more effectively prevents the conversion of penumbral tissue into permanent infarction in distal territories.
Clinical Implications of Radiographic Success
The technical success of the procedure served as a primary driver for tissue preservation, as the odds for reaching a Vrel of 0.8 or greater were significantly higher with successful reperfusion compared with no successful reperfusion (aOR, 2.5; 95% CI, 1.3 to 4.8). This finding underscores the biological efficacy of mechanical intervention: by successfully opening the vessel, clinicians were two and a half times more likely to salvage the vast majority of the penumbra. These radiographic improvements at the 24 hour mark translated into tangible benefits for patients during the clinical follow up conducted at 90 days. The researchers found that patients with a Vrel of 0.8 or greater had a better clinical outcome at 90 days than those with more extensive infarct expansion. Notably, this correlation between radiographic success and functional recovery was observed in both treatment groups, suggesting that any mechanism of tissue preservation, whether through spontaneous recanalization or mechanical thrombectomy, directly influences long term prognosis. For the practicing clinician, these findings provide a clear biological basis for endovascular therapy in distal vessel occlusion stroke, as the treatment effectively limits infarct expansion and preserves the neural substrates necessary for functional independence.
References
1. Berkhemer OA, Fransen P, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. New England Journal of Medicine. 2014. doi:10.1056/nejmoa1411587
2. Saver JL, Goyal M, Lugt AVD, et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016. doi:10.1001/jama.2016.13647
3. Ghozy S, Hardy N, Sutphin DJ, Kallmes K, Kadirvel R, Kallmes D. Common Data Elements Reported in Mechanical Thrombectomy for Acute Ischemic Stroke: A Systematic Review of Active Clinical Trials. Brain Science. 2022. doi:10.3390/brainsci12121679
4. Alhamdan Q, Ahmed I, Alajaji R, et al. Effectiveness of endovascular thrombectomy for mild stroke patients; systematic review. International Journal of Medicine in Developing Countries. 2024. doi:10.24911/ijmdc.51-1712661974
5. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2013. doi:10.1161/str.0b013e318284056a
6. Mead G, Sposato LA, Silva GS, et al. A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization. International Journal of Stroke. 2023. doi:10.1177/17474930231156753
7. Campbell B, Mitchell P, Kleinig T, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. New England Journal of Medicine. 2015. doi:10.1056/nejmoa1414792
